United Therapeutics (UTHR) Gross Margin Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 631.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -673.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -675.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -838.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 33.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -344.00 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 596.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -675.00 |
| Dec 31, 2025 | -112.00 |
| Sep 30, 2025 | -541.00 |
| Jun 30, 2025 | -461.00 |
| Mar 31, 2025 | -604.00 |
| Dec 31, 2024 | -198.00 |
| Sep 30, 2024 | -487.00 |
| Jun 30, 2024 | -255.00 |
| Mar 31, 2024 | -469.00 |
| Dec 31, 2023 | -251.00 |
| Sep 30, 2023 | -519.00 |
| Jun 30, 2023 | -359.00 |
| Mar 31, 2023 | -375.00 |
| Dec 31, 2022 | -271.00 |
| Sep 30, 2022 | 101.00 |
| Jun 30, 2022 | 79.00 |
| Mar 31, 2022 | 242.00 |
| Dec 31, 2021 | 3.00 |
| Sep 30, 2021 | 635.00 |
| Jun 30, 2021 | 555.00 |